Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2025 - 2030
-100%
Report Coverage
Mexico

Mexico pharmaceutical market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico pharmaceutical market, 2018-2030 (US$M)

Mexico pharmaceutical market highlights

  • The Mexico pharmaceutical market generated a revenue of USD 8.0 million in 2023 and is expected to reach USD 14.0 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
  • In terms of segment, conventional drugs (small molecules) was the largest revenue generating molecule type in 2023.
  • Biologics & Biosimilars (Large Molecules) is the most lucrative molecule type segment registering the fastest growth during the forecast period.


Pharmaceutical market data book summary

Market revenue in 2023USD 8.0 million
Market revenue in 2030USD 14.0 million
Growth rate8.3% (CAGR from 2023 to 2030)
Largest segmentConventional drugs (small molecules)
Fastest growing segmentBiologics & Biosimilars (Large Molecules)
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)
Key market players worldwideMerck & Co Inc, Roche Holding AG, Novartis AG ADR, AbbVie Inc, Johnson & Johnson, Pfizer Inc, Bristol-Myers Squibb Co, Sanofi SA, GSK PLC, Takeda Pharmaceutical Co Ltd


Other key industry trends

  • In terms of revenue, Mexico accounted for 0.5% of the global pharmaceutical market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil pharmaceutical market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 14.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmaceutical Market Companies

Name Profile # Employees HQ Website

Mexico pharmaceutical market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical market will help companies and investors design strategic landscapes.


Conventional drugs (small molecules) was the largest segment with a revenue share of 55% in 2024. Horizon Databook has segmented the Mexico pharmaceutical market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Mexico pharmaceutical market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico pharmaceutical market databook

  • Our clientele includes a mix of pharmaceutical market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico pharmaceutical market , including forecasts for subscribers. This country databook contains high-level insights into Mexico pharmaceutical market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico Pharmaceutical Market Outlook Share, 2024 & 2030 (US$M)

Related industry reports

No records

No related industry reports found.

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more